Stroke Rehabilitation System Biomove 5000 Approved by the US FDA

Share Article

The US FDA approves marketing of the most advanced Stroke Rehabilitation system in the world, manufactured by the Israeli company Curatronic Ltd.

Curatronic Ltd. announced today that it has obtained U.S. Food and Drug Administration (FDA) marketing approval for their new Biomove 5000 Stroke Rehabilitation system.

The Biomove 5000 offers very clear audiovisual biofeedback information in combination with muscle stimulation to the stroke survivor, making application not only straight forward in clinical settings but also for use by the stroke survivor at home.

The one knob operated full automatic device detects extremely small electrical EMG signals that persist in spastic muscles after a stroke and uses these tiny signals to initiate electrical stimulation impulses to these muscles, resulting in actual muscle movement. In addition to stroke rehabilitation the new device is also well suited for use with patients suffering from muscle paralysis after Spinal Cord Injury (SCI), Cerebral Palsy (CP) or Traumatic Brain Injury (TBI).

In the United States more than 700,000 individuals experience a stoke each year. Millions of people suffer from the debilitating effects of stroke. Fifty percent have one-sided paralysis and seek effective treatment for their severe, long-term disabilities.

Ben Philipson, President of Curatronic Ltd. said, "We are very pleased to have now also received FDA marketing approval for the new Biomove 5000 system, in addition to the Biomove 3000 home system already successfully marketed, enabling us to offer this superior and very easy-to-use stroke rehabilitation system to the many stroke survivors in the United States. In addition, our CE certification enables us to start marketing of this new device in Europe as well."

Further information about the new Biomove 5000 system can be found at the Biomove web site:

Curatronic Ltd. was founded in 2000 as a privately held R&D company dedicated to developing easy to use state-of-the-art stroke rehabilitation and therapy devices for use by patients at home and clinics.

Curatronic Ltd.
P.O.Box 1532
73127 Israel
Tel: 011-972-8976-1441
Fax: 011-972-8976-2020

After obtaining FDA certification in the USA and being awarded CE certification in Europe, Curatronic now starts marketing of the very easy-to-use new Stroke Therapy device Biomove 5000


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Email >

Ben Philipson
Visit website